Duncan Williams Analyst Recommendations & Stock Picks This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Duncan Williams. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Duncan Williams. Country All Countries United States(NYSE & NASDAQ) United States(All Exchanges) Canada United Kingdom Sector All Sectors Aerospace Auto/Tires/Trucks Basic Materials Business Services Computer and Technology Construction Consumer Discretionary Consumer Goods Consumer Staples Finance Industrials Medical Miscellaneous Multi-Sector Conglomerates Energy Retail/Wholesale Services Transportation Utilities All Market Caps Large Cap ($10B+) Medium Cap ($2B-$10B) Small Cap (<$2B) Market Cap MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.Available with a MarketBeat All Access SubscriptionMarketRank™Upgrade to All Access to use the All Ranks Filter Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.Available with a MarketBeat All Access SubscriptionMedia SentimentUpgrade to All Access to use the All Sentiments Filter Analyst consensus is the average investment recommendation among Wall Street research analysts.Available with a MarketBeat All Access SubscriptionAnalyst ConsensusUpgrade to All Access to use the All Ratings Filter Export to Excel CompanyCurrent PriceRating DateActionBrokerageAnalystRatingPrice TargetImpact on PriceDetailsActionsHCSGHealthcare Services Group$9.37-1.6%10/13/2011Downgraded byDuncan Williams-Buy -> HoldN/AView details for Duncan Williams rating of Healthcare Services Group (NASDAQ:HCSG) on 10/13/2011HPHelmerich & Payne$19.77-4.0%7/25/2011Downgraded byDuncan Williams-Buy -> Reduce$72.00N/AView details for Duncan Williams rating of Helmerich & Payne (NYSE:HP) on 7/25/2011RIGTransocean$2.13-6.6%7/14/2011Reiterated byDuncan Williams-Strong Buy -> Buy$101.25N/AView details for Duncan Williams rating of Transocean (NYSE:RIG) on 7/14/2011CPIXCumberland Pharmaceuticals$4.49-5.7%6/29/2011Reiterated byDuncan Williams-HoldN/AView details for Duncan Williams rating of Cumberland Pharmaceuticals (NASDAQ:CPIX) on 6/29/2011HPHelmerich & Payne$19.77-4.0%5/9/2011Upgraded byDuncan Williams-Reduce -> Strong Buy$72.00N/AView details for Duncan Williams rating of Helmerich & Payne (NYSE:HP) on 5/9/2011NEBLQNoble$0.055/9/2011Upgraded byDuncan Williams-Reduce -> Strong Buy$54.00N/AView details for Duncan Williams rating of Noble (OTCMKTS:NEBLQ) on 5/9/2011ERESEast Resources Acquisition$8.15+1.6%5/3/2011Reiterated byDuncan Williams-BuyN/AView details for Duncan Williams rating of East Resources Acquisition (NASDAQ:ERES) on 5/3/2011RIGTransocean$2.13-6.6%4/28/2011Upgraded byDuncan Williams-Reduce -> Strong Buy$93.00N/AView details for Duncan Williams rating of Transocean (NYSE:RIG) on 4/28/2011ICUIICU Medical$136.72-1.4%4/15/2011Reiterated byDuncan Williams-BuyN/AView details for Duncan Williams rating of ICU Medical (NASDAQ:ICUI) on 4/15/2011MMSIMerit Medical Systems$89.60-1.4%4/15/2011Reiterated byDuncan Williams-HoldN/AView details for Duncan Williams rating of Merit Medical Systems (NASDAQ:MMSI) on 4/15/2011HPHelmerich & Payne$19.77-4.0%4/4/2011Downgraded byDuncan Williams-Buy -> ReduceN/AView details for Duncan Williams rating of Helmerich & Payne (NYSE:HP) on 4/4/2011GPNGlobal Payments$67.51-2.8%4/1/2011Target Raised byDuncan Williams-Buy$26.00 -> $27.50N/AView details for Duncan Williams rating of Global Payments (NYSE:GPN) on 4/1/2011NEBLQNoble$0.053/3/2011Downgraded byDuncan Williams-Hold -> ReduceN/AView details for Duncan Williams rating of Noble (OTCMKTS:NEBLQ) on 3/3/2011RIGTransocean$2.13-6.6%2/25/2011Downgraded byDuncan Williams-Buy -> ReduceN/AView details for Duncan Williams rating of Transocean (NYSE:RIG) on 2/25/2011TDWTidewater$33.25-3.0%2/11/2011Initiated byDuncan Williams-Buy$62.00N/AView details for Duncan Williams rating of Tidewater (NYSE:TDW) on 2/11/2011HPHelmerich & Payne$19.77-4.0%2/2/2011Initiated byDuncan Williams-Buy$66.00N/AView details for Duncan Williams rating of Helmerich & Payne (NYSE:HP) on 2/2/2011EVRIEveri$13.75-0.1%1/28/2011Upgraded byDuncan Williams-Buy$4.00N/AView details for Duncan Williams rating of Everi (NYSE:EVRI) on 1/28/2011NBRNabors Industries$28.24-8.6%1/27/2011Initiated byDuncan Williams-Buy$45,000.00 -> $1,400.00N/AView details for Duncan Williams rating of Nabors Industries (NYSE:NBR) on 1/27/2011NEBLQNoble$0.051/26/2011Downgraded byDuncan Williams-HoldN/AView details for Duncan Williams rating of Noble (OTCMKTS:NEBLQ) on 1/26/2011PTENPatterson-UTI Energy$5.88-3.1%1/21/2011Initiated byDuncan Williams-Buy$24.00N/AView details for Duncan Williams rating of Patterson-UTI Energy (NASDAQ:PTEN) on 1/21/2011CPIXCumberland Pharmaceuticals$4.49-5.7%1/14/2011Upgraded byDuncan Williams-Reduce -> HoldN/AView details for Duncan Williams rating of Cumberland Pharmaceuticals (NASDAQ:CPIX) on 1/14/2011CPIXCumberland Pharmaceuticals$4.49-5.7%12/22/2010Downgraded byDuncan Williams-ReduceN/AView details for Duncan Williams rating of Cumberland Pharmaceuticals (NASDAQ:CPIX) on 12/22/2010FISFidelity National Information Services$76.40+2.4%12/7/2010Reiterated byDuncan Williams-Buy$32.00N/AView details for Duncan Williams rating of Fidelity National Information Services (NYSE:FIS) on 12/7/2010 MarketBeat Community Rating for Duncan WilliamsCommunity Ranking: 2.6 out of 5 (2.6 of 5 stars)Outperform Votes: 44,274 (Vote Outperform)Underperform Votes: 41,221 (Vote Underperform)Total Votes: 85,495MarketBeat's community ratings are surveys of what our community members think about Duncan Williams and other research firms. Vote "Outperform" if you believe Duncan Williams's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Duncan Williams's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days. Stock Forecasts and Research Tools Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
